Developing a multidisciplinary HCV direct-acting antivirals utilization management and assessment program.
J Am Pharm Assoc (2003). 2021 Mar-Apr;61(2):e159-e170. doi: 10.1016/j.japh.2020.11.008. Epub 2020 Dec 9.
J Am Pharm Assoc (2003). 2021.
PMID: 33309191